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To assess the effect of a research prioritization partnership that aimed 
to influence the research agenda relating to urinary incontinence.  
Study design and setting 
Research often neglects important gaps in existing evidence so that 
decisions must be made about treatments without reliable evidence of 
their effectiveness. In 2007-9 a UK partnership of 8 patient and 13 
clinician organizations identified and prioritized gaps in the evidence 
that affect everyday decisions about treatment of urinary 
incontinence. The top ten prioritized research questions were published 
and reported to research funders in 2009. 
A year later, new research or funding applications relating to the 
prioritized topics were identified through reviews of research databases 
and consultation with funding organizations, elements of the research 
community and organizations that participated in the partnership. 
Results 
Since dissemination of the prioritized topics, five studies are known to 
have been funded, three in development; five new systematic reviews 
are under way, one is being updated; five questions are under 
consideration by a national research commissioning body. 
Conclusion 
The partnership successfully developed and employed a methodology 
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for identification and prioritization of research needs through patient-
clinician consensus. Prioritization through consensus can be effective in 
informing the development of clinically useful research. 
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Despite its huge volume and scope, much of health care research is 
not targeted well, so that important gaps in the existing evidence base 
are neglected. In every clinical area there are commonly asked 
questions that remain unanswered by research. As a result clinicians 
and patients must make decisions about treatments without reliable 
evidence about their effectiveness. The James Lind Alliance (JLA) is an 
initiative that encourages patients and clinicians to work together in 
health research. One approach used is partnerships of patient and 
clinician organizations that work together to identify and prioritize the 
most pressing research needs in a particular clinical area. 
 
The JLA Priority Setting Partnership (PSP) on urinary incontinence (UI) 
was a partnership of twenty-one UK patient and clinician organizations 
that identified and then prioritized gaps in the evidence that affect 
everyday clinical decisions relating to the treatment of urinary 
incontinence. The partnership was originally proposed in 2007 by 
representatives of a UK charity, the Bladder and Bowel Foundation, 
and the Cochrane Incontinence Review Group. It completed its work 
in 2009. 
 
When the JLA PSP on urinary incontinence began, few projects of its 
kind had been completed. Mapping studies that have examined 
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research prioritization exercises internationally found that only a 
handful of projects had featured clinicians and patients working 
together to identify specific research questions(1, 2). Thus a 
methodology had to be developed that would be systematic and 
transparent and at the same time flexible and inclusive, so that all the 
potential stakeholder organizations with an interest in the area could 
become involved. The methods devised have been widely reported 
elsewhere and hence are described only in brief below(3-9).  
 
The principal output of the JLA PSP on urinary incontinence was a list of 
ten research questions that were identified as priority issues  by 
clinicians and patients working together. This report considers the 
impact that the work of the JLA PSP on urinary incontinence, and the 
dissemination of that list of ten prioritized research questions have had 




The methods of the JLA PSP on UI 
 
In brief, the process involved five phases. In the first phase, 30 UK 
clinician and patient organizations whose area of interest included 
urinary incontinence were identified through web searches and peer 
consultation, and invited to participate. Eight patient and thirteen 
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clinician groups participated, including both large organizations such 
as royal colleges and national patient charities, and small organizations 
with specific clinical interests.  
 
In the second phase, participating organizations asked their members 
to identify questions about the treatment of urinary incontinence for 
which no evidence-base was available, regularly affecting their ability 
to make treatment decisions. An issue was considered “uncertain” if no 
up to date systematic review of research evidence provided reliable 
guidance as to the best treatment. Subsequently 417 individual 
submissions were received. In addition, a further 131 unanswered 
research questions were identified from the recommendations of 
systematic reviews and clinical guidelines.  
 
The third phase involved collating and refining these questions: similar 
questions were combined while in some cases multiple questions were 
derived from a single submission; some were excluded because a 
systematic review that addressed them was identified; each was re-
written in PICO format (population, intervention, comparator, 
outcome)(10). The final database contained 226 uncertainties: 79 
came from patients; 37 from clinicians; six from both patients and 
clinicians; two from both patients and research recommendations; and 
102 from research recommendations alone.  
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In the fourth phase a two-stage strategy was employed to identify and 
prioritize, through consensus of clinician and patients representatives, a 
“top ten” unanswered research questions relating to urinary 
incontinence. First, each participating organization shortlisted 10 
questions from the database through consultation with their 
membership. These shortlists were then combined to produce a 
combined penultimate shortlist of 29. Second, at a workshop of patient 
and clinician organization representatives, nominal group techniques 
were used to reach a consensus on a ranked list of ten important 
clinical uncertainties. Prioritized uncertainties were verified by searching 
to ensure no up to date systematic reviews had been published that 
answered the questions. Of the top 10, five were originally submitted by 
clinicians, four by patients and one came from research 
recommendations.  
 
The fifth phase focused on disseminating the findings of the PSP with 
the dual aims of acting as a catalyst for research design and funding 
applications and of informing funding decisions. The final prioritized list 
was published in Neurourology and Urodynamics, the journal of the 
International Continence Society(8) and presented at meetings and 
conferences nationally and internationally, including the annual 
conference of the National Institute of Health and Clinical Excellence 
and the Cochrane Colloquium(11).  
 
 8 
The final list was also reported to the National Institute for Health 
Research’s Evaluation, Trials and Studies Coordinating Centre, which 
considers research questions for subsequent calls for Health Technology 
Assessment (HTA) programme research funding applications. Topics 
submitted to the HTA programme enter a further selection process and, 
if prioritized, a commissioning brief is advertised and the research 
community is alerted by emails and through the HTA website. The 
prioritized topics were also reported to the International Consultation 
on Incontinence Research Society and the Pelvic Floor Clinical Studies 




Assessing the impact of the JLA PSP on urinary incontinence 
 
In late 2010, nearly a year after the dissemination of the PSP’s findings, 
information has been collected about the effect the work has had on 
research activity. Funding agencies and sections of the research 
community and organizations that were connected with the PSP have 
been consulted to identify new research in development that relates 
to the work of the PSP. In addition, databases of trials and funded 
research have been searched. Investigators and relevant organization 
representatives have been contacted to establish which identified 
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research activities have been at least in part prompted by the activity 




For each of the prioritized questions in turn, information is presented 
about research that is known be in development or for which funding 
applications have been made. 
 
Prioritized question 1: What are the optimal pelvic floor muscle training 
protocols (frequency and duration of therapy) for the treatment of 
different patterns of urinary incontinence?  
Pelvic floor muscle training is widely recommended and practiced as a 
treatment in many urinary incontinence scenarios, and yet there is 
considerable uncertainty with regards to which types of urinary 
incontinence it can treat best and which are the most effective and 
acceptable exercise protocols(13, 14). A UK-centred international 
consortium of researchers is developing a research programme aimed 
at first identifying and then testing regimens of pelvic floor muscle 
training, involving different intensities and behavioural strategies, for the 
optimal treatment of female urinary incontinence. The question has 
been accepted into the HTA programme selection process so that a 
related commissioning brief may be developed. Both these processes 
will take into account the results of a recently completed systematic 
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review and economic modelling of non-surgical treatments for the 
condition(15).  A Cochrane Systematic Review entitled “One type of 
pelvic floor muscle training versus another for urinary incontinence in 
women” is being updated. 
 
Prioritized question 2: Can guidance or training for general practitioners 
on appropriate pathways of care improve the management of 
patients with urinary incontinence?  
Research to determine whether training for GPs about urinary 
incontinence pathways of care was extremely highly placed 
particularly by patient groups, perhaps because whilst the majority of 
those affected by urinary incontinence who seek help do so from their 
GP, there are concerns that GPs may not be sufficiently trained to 
diagnose, treat and refer appropriately9 25 26. This question was 
transferred from the HTA programme to the Service Delivery 
Organization (SDO) programme for consideration but there are no 
reports of it being developed further so far. 
 
Prioritized question 3: What is best practice for the treatment of 
combined stress urinary incontinence and detrusor overactivity?  
The question was combined in the HTA programme selection process 
with ‘A well-designed high quality RCT is needed to investigate the 
effectiveness of pelvic floor muscle training (PFMT) versus intensive 
pelvic floor muscle training (IPFMT) to treat combined stress and 
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urgency urinary incontinence.’ A Cochrane Systematic Review entitled 
“Combined conservative interventions for urge and stress, or mixed 
urinary incontinence in adults” is under way. Research is in 
development that will consider the treatment of mixed urinary 
incontinence. The Pelvic Floor Clinical Studies Group has awarded a 
grant to develop a project studying surgical management of stress 
incontinence in women with mixed urinary incontinence.  
 
Prioritized question 4: What catheter regimens are most effective in 
preventing urinary tract infections in patients using intermittent self-
catheterisation for the management of a neurogenic bladder? What is 
the effectiveness and safety of prophylactic versus symptomatic 
antibiotic therapy in patients with neurogenic bladder dysfunction 
using intermittent self-catheterisation?  
The management of bladder dysfunction resulting from neurogenic 
disease or trauma is of crucial importance to rehabilitation and quality 
of life and yet Cochrane Systematic Reviews in this area have found 
little evidence to inform best practice(16). Two questions have been 
combined in this priority as they both address the same issue. A major 
concern in bladder management in this context is the preservation of 
upper urinary tract health and avoidance of renal damage. 
Catheterization is performed to prevent renal damage resulting from 
hyronephrosis as well as to achieve social continence, but itself can 
increase the risk of urinary tract infection, another renal damage risk 
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factor. Various catheter regimens and prophylactic use of antibiotocs 
have been considered to have potential in preventing such infections. 
The first of these combined questions has been referred to the External 
Devices and Physical Therapies Panel within the HTA programme topic 
selection process. The second will be considered by the 
Pharmaceuticals Panel. A prospective study that will explore the 
experience of people with multiple sclerosis who use intermittent 
catheterisation and reasons for cessation has been funded by the 
Multiple Sclerosis Society.  
 
Prioritized question 5: Which treatment is most effective for the 
reduction of urinary frequency and urgency?  
Urinary urgency and frequency, the symptoms of overactive bladder, 
are frequently found concomitantly and the question of which 
treatment is most effective is a pressing one. Yet few studies have 
compared behavioural therapy with common anticholinergics, while 
there are no industry-independent comparisons of the numerous 
anticholinergics available to assess efficacy and cost effectiveness. A 
systematic review has highlighted unresolved questions(17). As of late 
2010, no new research activity has been identified. Comparison of 
anticholinergic drugs, bladder training or a combination of both for 
combined frequency and urgency has been accepted into the HTA 




Prioritized question 6: Is urodynamic testing prior to surgery for urinary 
incontinence associated with better continence rates and quality of 
life, than surgery indicated without such testing?  
Although used widely, the effectiveness of urodynamic testing in 
informing choice of surgery for incontinence is far from clear, as 
highlighted by recent NICE recommendations (18). Following an 
application which resulted from the PSP’s work, the NIHR HTA 
Programme has approved funding for a large multicentre pilot study to 
assess the feasibility of a future randomised controlled trial. 
 
Prioritized question 7: What is best practice for the management of 
stress urinary incontinence following failed tension free vaginal tape 
surgery?  
Suburethral tapes are the commonest operation for urodynamic stress 
incontinence in women. But it is not clear what is best for the 10% of 
women whose operation fails. Options include medical and surgical 
treatment. Specific questions include: whether an abdominal 
procedure (eg. colposuspension) is more effective than a repeat 
suburethral tape insertion; and whether the failed tape should be 
excised. There are no robust comparative data to inform decision-
making. A new Cochrane Systematic Review entitled “Treatment of 
urinary incontinence after failed minimally invasive sling surgery in 
women” is under way. 
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Prioritized question 8: What are the most effective treatments of 
daytime urinary incontinence in children?  
While there is extensive evidence to guide the management of night-
time bed wetting in children, this is not true for childhood daytime 
incontinence (19-24). A Cochrane Systematic Review entitled 
“Treatments for daytime urinary incontinence in children” is under way. 
Researchers are also developing a paediatric patient-reported 
outcome measure for urinary incontinence. Finally, a UK study has 
been funded comparing treatments for daytime UI in children. 
 
Prioritized question 9: Are disposable catheters more or less acceptable 
than reusable catheters, in terms of effective bladder management, 
patient experience and urinary tract infections?  
Whilst single-use catheters have been widely promoted and accepted 
in the UK for intermittent self-catheterisation, their clinical effectiveness 
compared with re-usable catheters is unclear. Thus patients are rarely 
offered re-usable catheters although they may prefer them for 
environmental reasons and ease of storage. In addition, in the 
absence of evidence of clinical effectiveness, the very significant 
difference in costs to health care systems would appear unjustified(25). 
The topic has been referred to the External Devices and Physical 
Therapies Panel in the HTA programme’s selection process. A 
programme of research entitled “Improving choice and cost-
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effectiveness for people using intermittent catheterisation” is in 
development by an international collaboration of researchers. 
 
Prioritized question 10: In women with prolapse and stress urinary 
incontinence, should suburethral tapes be inserted at the same time as 
repairing the prolapse?  
When a woman in whom SUI is pre-existing is undergoing prolapse 
repair surgery, should a continence procedure such as suburethral 
tapes should be performed at the same time (26, 27)? There is little in 
the way of evidence to help patients and clinicians to make the 
decision. Two new Cochrane Systematic Reviews are under way with 
support from the UK’s Cochrane Incentive Scheme that will specifically 
address whether women with prolapse and UI should have a 
concomitant UI procedure with prolapse surgery and whether women 
without urinary incontinence should undergo a subsequent 
prophylactic urinary incontinence procedure.  
 
Discussion and conclusions 
 
The breadth of urinary incontinence as a clinical area was reflected in 
the wide range of evidence needs included in the final list. Each 
prioritized question related to uncertainties about treatment and 
management strategies that have profound effects on quality of life 
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and rehabilitation of those affected by urinary incontinence, and yet 
little evidence exists to guide practice.   
 
In order to identify new research activity in the wake of the JLA PSP on 
urinary incontinence, this report has relied upon searching of research 
databases and consultation with sections of the research community, 
organizations that were connected with the PSP and with the funding 
bodies. Consultation identified a good deal of research activity related 
to the work of the PSP. Research databases revealed no further 
activity. Other research may be in preparation or under way that has 
not been identified: funding applications are often confidential; 
research databases publish only approved funding or research that is 
under way; and the time taken in the preparation and consideration of 
applications means that there is a delay in publication. The absence of 
published or citable sources must affect the degree to which the 
outcomes described in this report might be considered “robust” by 
health research standards. In addition, academic confidentiality has 
necessarily affected the potential to identify research activities 
included in this report.  
 
As with other activity that takes place in broad and complex 
environments, such as health promotion interventions, measuring the 
precise impact of a PSP is challenging: it is difficult to be sure what 
activities are the direct result of the work and which may have 
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occurred anyway. Only activities known to have resulted at least in 
part as a result of the work of the JLA PSP on urinary incontinence have 
been included in this report.  It must be borne in mind that this work is 
UK based: many aspects of the work, including the prioritization 
process, the research priorities identified and the relevant research 
funding mechanisms may not be applicable or relevant in many other 
regions. The issue of prioritization at an international level is an 
important one that deserves further attention. 
 
Despite the difficulties in assessing the impact of the work, the JLA PSP 
on urinary incontinence would appear to have had considerable 
impact as a catalyst for research activity. Five studies are known to 
have been funded and several more are in development, addressing 
six of the ten priorities. Arguably, an up to date systematic review 
should underpin research developed to address all the priorities. A 
number of Cochrane systematic reviews have been initiated or are 
being updated. Some are known to have been in direct response to 
the PSP work, while the others are happening in the context of the 
Cochrane review group that was integrally involved with the PSP so 
that it is likely to have had some influence, if indirect. Whilst the 
potential value of systematic reviews to patients and clinicians seeking 
answers to treatment questions is undoubted, reviews often find no 
evidence or inconclusive evidence and so are of little direct 
assistance. In a 2010 survey, 9% of all published Cochrane Reviews 
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found no trials at all eligible for inclusion(28). A great many more were 
inconclusive. However, although these “empty” or inconclusive reviews 
are of little assistance to patients or clinicians, they can be useful in 
refining research questions and stimulating new research. 
 
Several of the topics are under consideration by the UK’s major funding 
agency for research commissioning calls. This process is complex, and 
the PSP has been unable to maintain influence with regards to the 
progress of the topics. Concerns have been expressed to the body 
that the specific questions identified and prioritized by patient and 
clinician consensus might be altered by the body’s own topic 
prioritization process. The topics have also been recognized by two 
academic groups that have an interest in incontinence research so 
that they will be considered by the international research community. 
For only one of the ten prioritized questions has no specific related 
activity been identified. 
 
Although the PSP appears to have been effective, there are aspects of 
the work that need to be considered.  One is the degree to which 
those involved in the PSP are instrumental in driving any impact on 
subsequent research activity. Research groups were excluded from the 
topic submission and prioritization process because it was felt that 
there would be conflicts of interest. However, there exists an overlap 
between clinicians and patient organization representatives and 
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researchers so that individual researchers were involved in the PSP. In 
the months following the PSP most research developments involved 
those that took part in the PSP so that there was concern about the 
breadth of impact; however, the impact appears to have spread, as 
more recently research has emerged in development or under way 
that involves nobody involved in PSP. Thus the perception that the 
impact was restricted initially to those with direct involvement may 
have been accurate, or it may have been an effect of the confidential 
nature of research development. Whether there is harm or benefit 
associated with an initial influence of those involved in the PSP is 
uncertain and may be an issue worth further consideration. The JLA PSP 
on urinary incontinence endeavoured to ensure wide dissemination of 
its work to researchers not involved. For all researchers developing 
funding applications, a peer-reviewed publication disseminating the 
results of prioritization work provides a valuable reference.  
 
Another aspect that may warrant consideration is how to maintain the 
impact of the work in the future. Although this will be assisted by the 
publication of new systematic reviews with research 
recommendations, it is questionable if this will be sufficient.  
 
Another factor for consideration is that some of the questions prioritized 
were very broad in their scope. As a result it may have been hard for 
researchers to be clear about the most appropriate research response. 
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As with research recommendations generally, future PSPs should 
perhaps generate more specific and carefully constructed research 
questions(29). That said, whereas concise research questions may suit 
the research establishment, the approach might not facilitate greater 
patient inclusion in research prioritization. Work in New Zealand that 
involved citizens’ juries comprising women with urinary incontinence 
and looked at their research priorities reported patient interests in 
broad questions about quality of life, day-to-day management and 
costs, service delivery and access to services. The one question 
prioritized by both the JLA PSP on UI and the New Zealand work was 
one that related to education and training for GPs. The New Zealand 
participants were dismissive of commonly used research outcomes 
such as pad tests and bladder diaries, considering them unrealistic and 
likely to lack validity(30).  
 
In conclusion, the PSP successfully developed and employed a 
methodology for identification and prioritization of research needs by 
patient-clinician consensus and appears to have been effective in 
informing the development of clinically useful research. Work is needed 
to further develop practical and valid methods for prioritization of 
research topics that involve both patients and clinicians both on 
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Table 1: Identified research activity associated with the James Lind Alliance Priority Setting 
Partnership on Urinary Incontinence. 









1. Pelvic floor training 
yes  Updated yes 
2. GP training or 
guidance 
    
3. Mixed stress & urge 
UI 
yes yes New yes 
4. Neurogenic bladder 
management 
 yes   yes 
5. Mixed frequency & 
urgency 
   yes 
6. Effectiveness of 
urodynamics 
 yes   
7. Failed tape surgery 
  New  
8. Daytime UI in 
children 
 yes x 2 New  
9. Disposable/reusable 
catheters 
yes   yes 
10. Concomitant SUI & 
prolapse surgery 
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